An assembled panel includes a mix of entrepreneurs, researchers from academia and industry, and a practicing physician-scientist and his patients. They will discuss the medical and patient needs related to hearing loss and otitis, the research and development challenges and the business opportunities in this fast evolving field.
Hearing loss presents a growing public health problem due to aging, disease, and noise, with the latter disproportionally affecting the young. Overall, ~15% of the global population is affected across all age groups, leading to direct and indirect costs of untreated hearing loss totaling $750 billion.
Boston has emerged as a hotbed for medical and medtech innovation and academic leadership in inner ear therapies with leadership in drug delivery, regenerative therapies, otitis treatment and cochlear implants.
Wyss Technology Development Fellow Ida Pavlichenko, Ph.D. will be one of the presenters.